Article info
PDFSection 1: Introductory statements and governance
1ISG-013 Real-life data of CDK4/6 inhibitors palbociclib, ribociclib and abemaciclib in locally advanced or metastatic breast cancer: effectiveness evaluation
Citation
1ISG-013 Real-life data of CDK4/6 inhibitors palbociclib, ribociclib and abemaciclib in locally advanced or metastatic breast cancer: effectiveness evaluation
Publication history
- First published March 20, 2024.
Online issue publication
March 20, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ.